Diabetes Pharmacotherapy Update

The American Diabetes Association Standards of Care in Diabetes are a “living” guideline – the recommendations are updated throughout the year and major revisions occur in January. In this episode, guest host, Jake Galdo, is joined by Susan Cornell as they evaluate new pharmacotherapy recommendations in the ADA Standards of Care.The GameChangerTreatment recommendations for diabetes are no longer metformin plus. Now initial, and augmented therapy, is driven by comorbid conditions.Show Segments00:00 - Introductions02:09 - Reason for ADA Standards of Care Update05:09 - The GameChanger: Comorbid Condition-Driven Therapy08:32 - Connecting to Practice: Clinical Decision Points11:13 - Diabetes Therapies Use for Weight Loss and Drawbacks13:29 - Lifestyle Modification Suggestions19:48 - Insulin Use According to New Guidelines25:03 - Pharmacy Intervention Opportunity: Glucagon26:37 - Closing Remarks HostJohn A Galdo, PharmD, MBA, BCPS, BCGP (Jake)Director, Education Projects, CEimpactCEO, SeguridadGuestSusan Cornell, BS, PharmD, CDCES, FAPhA, FADCESAssociate Director, Experiential EducationProfessor, Pharmacy PracticeMidwestern University College of PharmacyReferences and ResourcesPharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes CareRedeem your CPE or CME hereCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membershipCE InformationLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Identify the first line therapy for treatment of diabetes2. Discuss key clinical decision points for the treatment of diabetes0.05 CEU/0.5 HrUAN: 0107-0000-23-023-H01-PInitial release date: 01/09/2023Expiration date: 01/09/2024Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram